Ads
related to: side effects of gemcitabine and docetaxel for bladder cancer disease patients- What Is ADSTILADRIN®?
Learn About Treatment With
ADSTILADRIN® And How It Works.
- Treatment Information
Learn More About What To Expect
When Taking ADSTILADRIN®.
- Support & Resources
View Patient Assistance, Coverage
Support, & Other Valuable Resources
- Discover ADSTILADRIN®
Talk To Your Doctor About If
ADSTILADRIN® Is Right For You.
- What Is ADSTILADRIN®?
Search results
Results From The WOW.Com Content Network
Gemcitabine, sold under the brand name Gemzar, among others, [1] is a chemotherapy medication used to treat cancers. [3] It is used to treat testicular cancer, [4] breast cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer. [3] [5] It is administered by intravenous infusion. [3]
Nausea and vomiting are two of the most feared cancer treatment-related side-effects for people with cancer and their families. In 1983, Coates et al. found that people receiving chemotherapy ranked nausea and vomiting as the first and second most severe side-effects, respectively. [98]
The majority of drugs used in cancer chemotherapy are cytostatic, many via cytotoxicity. A fundamental philosophy of medical oncology , including combination chemotherapy, is that different drugs work through different mechanisms, and that the results of using multiple drugs will be synergistic to some extent.
Other severe side effects include allergic reactions and future cancers. [6] Docetaxel induced pneumotoxicity is also a well recognized adverse effect which has to be identified timely and treated after withholding the drug. [8] Side effects are more common in people with liver problems. [6] Use during pregnancy may harm the baby. [6]
An alkylating antineoplastic agent is an alkylating agent used in cancer treatment that attaches an alkyl group (C n H 2n+1) to DNA. [1] Since cancer cells, in general, proliferate faster and with less error-correcting than healthy cells, cancer cells are more sensitive to DNA damage—such as being alkylated. Alkylating agents are used to ...
Bladder cancer is much more common in men than women; around 1.1% of men and 0.27% of women develop bladder cancer. [2] This makes bladder cancer the sixth most common cancer in men, and the seventeenth in women. [69] When women are diagnosed with bladder cancer, they tend to have more advanced disease and consequently a poorer prognosis. [69]
Ads
related to: side effects of gemcitabine and docetaxel for bladder cancer disease patients